Predicting cancer evolution for patient benefit: Renal cell carcinoma paradigmMore about Open Access at the Crick
Evolutionary features of cancer have important clinical implications, but their evaluation in the clinic is currently limited. Here, we review current approaches to reconstruct tumour subclonal structure setting and discuss tumour sampling method and experimental design influence. We describe clear-cell renal cell carcinoma (ccRCC) as an exemplar for understanding and predicting cancer evolutionary dynamics. Finally, we discuss how understanding cancer evolution can benefit patients.
Issue number 5
Full text links
Publisher website (DOI) 10.1016/j.bbcan.2022.188759
Download Download full text [pdf]
Europe PubMed Central 35835341
Type of publication